June 03, 2023 Asco 2023 – Pfizer pushes forward in drug-resistant breast cancer While Ibrance has been bested by class rivals, Pfizer is working on projects that might overcome CDK4/6 inhibitor resistance – though it is not alone.
April 27, 2020 Kevzara's Covid-19 setback shows need for hard evidence As investors continue to jump on small sparks of hope in the pandemic pipeline Sanofi and Regeneron inject a dose of reality.
